- Progress includes otenaproxesul’s new formulation, strengthened IP and robust third-party sales projections - Sale of Citagenix subsidiary provides non-dilutive funding - Ended quarter with $45.4 million in cash and equivalents, providing over two
Controlling shareholder provides loan facility TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceutica
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics®, today reported unaudited financial results for its second quarter e
- Initiated CALM Phase 3 program with topline data expected for CALM-1 and CALM-2 in the second half of 2024 and 2025, respectively - - Ended third quarter 2022 with US$364.4 million in cash, cash equivalents and short-term investments; Cash runway exte
DUBLIN--(BUSINESS WIRE)--The "Phosphoric Acid Market by Process Type (Wet, Thermal), Application (Fertilizers, Feed & Food Additives, Detergents, Water Treatment Chemicals, Metal Treatment, Industrial Use) and Region - Global Forecast to 2027" report
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that members of the management team will participat
Dr. Armand Balboni appointed as Chair of the Board and moves to the U.S. Air Force Academy to take over as Principal Investigator for the ATI-1701 program; and Dr. Don Cilla promoted to President and Chief Executive Officer of Appili HALIFAX, Nova Scotia
- Blexten Canadian Prescriptions Increased 27% Quarter-Over-Prior Year Quarter- - Suvexx Canadian Prescriptions Increased 86% Quarter-Over- Prior Year Quarter – Miravo to Host Conference Call/Audio Webcast November 14th at 11:00 a.m. ET MISSISSAUGA,
(All figures are in Canadian dollars, unless stated otherwise. Average exchange rate in Q3 2022: C$1.00 = R$3.99) SINGAPORE--(BUSINESS WIRE)--$NPK.TO #verdeagritech--Verde AgriTech Ltd (TSX: “NPK”) (OTCMKTS: "VNPKF") (“Verde” or the “Company”
DUBLIN--(BUSINESS WIRE)--The "Global Cannabis Market (2022-2027) by Form, Product Type, Compound, Source, Distribution Channel, Application, and Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to Rese
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.